(Q33703360)

28 July 2017

Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children (English)

1 reference

28 July 2017

0 references

1 reference

1 reference

B U Mueller

1

1 reference

28 July 2017

L L Lewis

2

1 reference

28 July 2017

G J Yuen

3

1 reference

28 July 2017

M Farley

4

1 reference

28 July 2017

A Keller

5

1 reference

28 July 2017

J A Church

6

1 reference

28 July 2017

J C Goldsmith

7

1 reference

28 July 2017

D J Venzon

8

1 reference

28 July 2017

M Rubin

9

1 reference

28 July 2017

P A Pizzo

10

1 reference

28 July 2017

F M Balis

11

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 December 1998

1 reference

Antimicrobial Agents and Chemotherapy

28 July 2017

1 reference

28 July 2017

42

1 reference

28 July 2017

12

1 reference

28 July 2017

3187-3192

1 reference

Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction.

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Lamivudine in children with human immunodeficiency virus infection: a phase I/II study. The National Cancer Institute Pediatric Branch-Human Immunodeficiency Virus Working Group

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infection.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Dideoxycytidine alone and in an alternating schedule with zidovudine in children with symptomatic human immunodeficiency virus infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2'-deoxy-3'-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Clinical pharmacology of 2',3'-dideoxyinosine in human immunodeficiency virus-infected children.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Cellular metabolism of (−) enantiomeric 2′-deoxy-3′-thiacytidine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Mlab — A mathematical modeling tool

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Phase I Evaluation of Zalcitabine Administered to Human Immunodeficiency Virus-Infected Children

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=106021

Simplification of drug dosage calculation by application of the surface area principle

30 October 2018

1 reference

12 December 2020

Pyrimidine dideoxyribonucleosides: selectivity of penetration into cerebrospinal fluid

1 reference

12 December 2020

Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells

1 reference

12 December 2020

High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum

1 reference

12 December 2020

Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Limited sampling model for vinblastine pharmacokinetics

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.42.12.3187

0 references

PMC publication ID

106021

1 reference

28 July 2017

1 reference